Document is current
Any future updates will be listed below
-
Authors
Angstadt, Shantel
Horn, Lucas A.
Fousek, Kristen
Rajabian, Nika
Qin, Haiyan
Medina-Enriquez, Miriam M.
Kelly, Marcus D.
Hsiao-Sanchez, Nicole
Meyer, Thomas J.
Moisan, Jacques
Katragadda, Madan
Bayliffe, Andrew
Su, Zhen
Schlom, Jeffrey
Palena, Claudia
-
Funding
Funding for this research was provided by:
CRADA between the NCI/NIH and Marengo Therapeutics
Intramural Research Program (ZIC BC 010937)
- License Information
-
More Information
Article History
Received: 1 May 2026
Accepted: 23 August 2026
First Online: 28 August 2026
Declarations
Ethics approval and consent to participate: All animal procedures reported in this study were approved by the NCI Animal Care and Use Committee (ACUC) and in accordance with federal regulatory requirements and standards. All components of the intramural NIH Animal Care and Use program are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.
Consent for publication: Not applicable.
Competing interests: The authors from Marengo Therapeutics are employees or officers of the company. CP discloses spouse’s employment and holdings in MacroGenics, Inc. All other authors from the National Cancer Institute, NIH, do not have any competing interests to disclose. The NCI, NIH has an ongoing Cooperative Research and Development Agreement (CRADA) with Marengo Therapeutics.
